✦ LIBER ✦

Clinical outcomes in elderly patients administered gefitinib as first-line treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer: retrospective analysis in a Nagano Lung Cancer Research Group Study

✍ Scribed by Kazunari Tateishi, Takashi Ichiyama, Kazuya Hirai, Toshihiko Agatsuma, Shigeru Koyama, Tsutomu Hachiya, Nobutoshi Morozumi, Takayuki Shiina, Tomonobu Koizumi

Book ID: 118821818
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 230 KB
Volume: 30
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-012-0450-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib as First-line Treatment in Eld

Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study

✍ Kazuhiro Asami; Tomonobu Koizumi; Kazuya Hirai; Shingo Ameshima; Akihiro Tsukada 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 308 KB

9123 POSTER Final Results of a Phase II

9123 POSTER Final Results of a Phase II Study of Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Non-small Cell Lung Cancer – Gefitinib for Elderly Patients With Lung Adenocarcinoma

✍ Asami, K.; Koizumi, T.; Hirai, K.; Ameshima, S.; Tsukadaira, A.; Morozumi, N.; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Epidermal growth factor receptor polymor

Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib

✍ Liu, G; Gurubhagavatula, S; Zhou, W; Wang, Z; Yeap, B Y; Asomaning, K; Su, L; He 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Gefitinib as first-line treatment for pa

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: Implications for clinical practice and open issues

✍ Gridelli, C.; De Marinis, F.; Di Maio, M.; Cortinovis, D.; Cappuzzo, F.; Mok, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 144 KB

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION TESTING AND FIRST LINE TREATMENT WITH GEFITINIB IS A DOMINANT STRATEGY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

✍ G. de Lima Lopes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCN109 Cost Effectiveness of First Line

PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Markov Model

✍ Borget, I.; Vergnenegre, A.; Chouaid, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB